logo

For the Inventor, By the Inventor

Aachen, Germany

Arne Gerlach

This inventor holds 2 USPTO granted patents. Top assignee: Degussa Aktiengesellschaft. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arne Gerlach. Retrieved from https://idiyas.com/inventor/arne-gerlach-xamq2kyz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:

goldMedal2 out of 1,694 
 
Degussa Aktiengesellschaft
 patents

Years Active: 2001

Loading Chart...
2 patents (USPTO):Explore Patents
1. 6326327 - Process for preparing MeO-Peg-protected dihydroquinine or dihydroquinidine derivatives, new dihydroquinine or dihydroquinidine derivatives and their use (2001-12-04),
2. 6180551 - Process for preparing MeO-Peg-protected dihydroquinine or dihydroquinidine derivatives, new dihydroquinine or dihydroquinidine derivatives and their use (2001-01-30),

Title: Arne Gerlach: Innovator in Dihydroquinine Derivatives

Introduction

Arne Gerlach is a notable inventor based in Aachen, Germany. He has made significant contributions to the field of chemistry, particularly in the development of dihydroquinine and dihydroquinidine derivatives. His work focuses on creating innovative ligand systems that enhance enantioselective reactions.

Latest Patents

Gerlach holds 2 patents related to the preparation and application of MeO-Peg-protected dihydroquinine and dihydroquinidine derivatives. His latest patents detail processes for forming these derivatives, which are recognized for their effectiveness as ligands in enantioselective dihydroxylation. The new ligand systems he has developed can be recycled after use, allowing for greater efficiency in chemical reactions.

Career Highlights

Arne Gerlach is associated with Degussa Aktiengesellschaft, a company known for its advancements in chemical production and innovation. His work has contributed to the company's reputation as a leader in the field. Gerlach's research has opened new avenues for the application of dihydroquinine and dihydroquinidine derivatives in various chemical processes.

Collaborations

Throughout his career, Gerlach has collaborated with esteemed colleagues such as Carsten Bolm and Karlheinz Drauz. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Arne Gerlach's contributions to the field of chemistry, particularly through his patents and collaborative efforts, highlight his role as a significant inventor. His work continues to influence the development of efficient chemical processes and innovative ligand systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…